Publication

cAMP-cependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Herve Schaffhauser, Emory University School of MedicineZhaohui Cai, Emory University School of MedicineFrantisek Hubalek, Emory University School of MedicineThomas A. Macek, Emory University School of MedicineJan Pohl, Emory UniversityThomas Murphy, Emory UniversityP. Jeffrey Conn, Emory University School of Medicine
Language
  • English
Date
  • 2000-08-01
Publisher
  • Society for Neuroscience
Publication Version
Copyright Statement
  • Copyright © 2000 Society for Neuroscience
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 20
Issue
  • 15
Start Page
  • 5663
End Page
  • 5670
Grant/Funding Information
  • This work was supported by National Institutes of Health (NIH)–National Institute of Neurological Diseases and Stroke (P.J.C.), NIH–NCRR (J.P.), NIH–National Heart, Lung, and Blood Institute (T.J.M.), and NARSAD grants (H.S., P.J.C.).
Abstract
  • One of the primary physiological roles of group II and group III metabotropic glutamate receptors (mGluRs) is to presynaptically reduce synaptic transmission at glutamatergic synapses. Interestingly, previous studies suggest that presynaptic mGluRs are tightly regulated by protein kinases. cAMP analogs and the adenylyl cyclase activator forskolin inhibit the function of presynaptic group II mGluRs in area CA3 of the hippocampus. We now report that forskolin has a similar inhibitory effect on putative mGluR2-mediated responses at the medial perforant path synapse and that this effect of forskolin is blocked by a selective inhibitor of cAMP-dependent protein kinase (PKA). A series of biochemical and molecular studies was used to determine the precise mechanism by which PKA inhibits mGluR2 function. Our studies reveal that PKA directly phosphorylates mGluR2 at a single serine residue (Ser843) on the C-terminal tail region of the receptor. Site-directed mutagenesis combined with biochemical measures of mGluR2 function reveal that phosphorylation of this site inhibits coupling of mGluR2 from GTP-binding proteins.
Author Notes
  • Correspondence should be addressed to P. Jeffrey Conn, Department of Pharmacology, Emory University School of Medicine, 5015 Rollins Research Center, Atlanta, GA 30322-3090. E-mail:pconn@emory.edu.
Keywords
Research Categories
  • Biology, Microbiology
  • Chemistry, Biochemistry

Tools

Relations

In Collection:

Items